TXA (Tranexamic Acid) Risk Evaluation in Combat Casualties (TRECC)
Background The use of tranexamic acid (TXA) has become increasingly prevalent for hemorrhage prevention in military trauma patients due to its known survival benefits. There is concern of increased venous thromboembolism (VTE) subsequent to receiving TXA. The purpose of this retrospective study was...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2020-12-01
|
| Edice: | Trauma Surgery & Acute Care Open |
| On-line přístup: | https://tsaco.bmj.com/content/5/1/e000353.full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|